Abstract
During the course of hepatitis B virus (HBV)infection, there exists a long period of normal liverfunction tests with different states of HBeAg/Ab. As thestate of HBV in asymptomatic carriers was not well characterized, we quantitatively andqualitatively examined HBV in both HBeAg-positive andanti-HBe-positive asymptomatic carriers. Sera from 10HBeAg-positive and 27 anti-HBe-positive asymptomatic carriers were analyzed. The amount of HBV DNAwas determined by dot-blot hybridization and polymerasechain reaction. The mutations in precore and coreregions, spanning 636 nucleotides, of hepatitis B virus were examined by directly sequencing theamplified HBV DNA. HBV DNA was detected in all 10 HBeAg-positive cases, whereas it was found in only 7 of 27(26%) anti-HBe-positive cases by the nested PCR method. The mean amount of HBV DNA inHBeAg-positive cases was 109.1±0.7copies/ml, while that in anti-HBe-positive cases was101.0±1.5 copies/ml. There were no 0.7missense mutations in the entire precore and core genes of HBV DNA taken fromHBeAg-positive asymptomatic carriers. In contrast, manymutations (mean 9.0 ± 3.3, range 6-14) weredetected in the core gene of seven anti-HBe-positiveasymptomatic carriers including two cases with increments of themutations. Analysis of the precore region revealed threewild-type and four mutant-type (including one coexistingwith wild-type) cases. These data suggest that HBV exists in quite different ways in“asymptomatic” carriers; in the HBeAg-positive phase HBV probably coexists with the host andremains as the wild type, whereas in theanti-HBe-positive phase a drastically reduced amount of HBV with many mutationsremains, probably as a consequence of the long-lastinginteraction with the host. Nevertheless, such smallamount of virus could cause fulminant hepatic failure. It is important to make further clinical andvirological investigations in order to understand thestate of asymptomatic carrier.
Similar content being viewed by others
REFERENCES
Hoofnagle JH, Shafritz DA, Popper H: Chronic type B hepatitis and the “ healthy” HBeAg carrier state. Hepatology 7:758 - 763, 1987
Shikata T, Karasawa T, Abe T, Uzawa T, Suzuki H, Oda T, Imai M, Mayumi M, Moritsugu Y: Hepatitis Be antigen and infectivity of hepatitis B virus. J Infect Disease 136:571- 576, 1977
Scotto J, Hadchoue l M, Hery C, Yvart J, Tiollais P, Brechot C: Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: Comparison with results for other viral markers. Hepatology 3:279 - 284, 1983
Lieberman HM, LaBrecque DR, Kew MC, Hadziyannis SJ, Shafritz DA: Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: Comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology 3:285- 291, 1983
Matsuyama Y, Omata M, Yokosuka O, Imazeki F, Ito Y, Okuda K: Discordance of hepatitis Be antigen/antibody and hepatitis B virus deoxyribonucleic acid in serum. Analysis of 1063 specimens. Gastroenterology 89:1104 - 1108, 1985
Hadziyannis SJ, Lieberman HB, Karvountzis GG, Shafritz DA: Analysis of liver disease, nuclear HBcAg, viral replication and hepatitis B virus DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus. Hepatology 3:656 - 662, 1983
Kaneko S, Miller RH, Di Bisceglie AM, Feinstone SM, Hoofnagle JH, Purcell RH: Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Gastroenterology 99:799 - 804, 1990
Yokosuka O, Omata M, Hosoda K, Tada M, Ehata T, Ohto M: Detection and direct sequencing of hepatitis B virus genome by DNA amplification method. Gastroenterology 100:175- 181, 1991
Baker BL, Di Bisce glie AM, Kaneko S, Miller R, Feinstone SM, Waggoner JG, Hoofnagle JH: Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: Clinical significance and correlation with serological markers. Hepatology 13:632- 636, 1991
Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, Mc-Garvey MJ, Makris A, Thomas HC: Mutation preventing formation of hepatitis Be antigen in patients with chronic hepatitis B infection. Lancet 2:588 - 591, 1989
Akahane Y, Yamanaka T, Suzuki H, Sugai Y, Tsuda F, Yotsumoto S, Omi S, Okamoto H, Miyakawa Y, Mayumi M: Chronic active hepatitis with hepatitis B virus DNA and antibody againt e antigen in the serum. Gastroenterology 99:1113- 1119, 1990
Brunetto MR, Giarin MM, Oliveri F, Chiaberge E, Baldi M, Alfarano A, Serra A, Sarcco G, Verme G, Will H, Bonino F: Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 88:4186 - 4190, 1991
Brunetto MR, Giarin M, Oliveri F, Saracco G, Barbera C, Parrella T, Abate ML: “ e” antigen defective hepatitis B virus and course of chronic infection. J Hepatol 13:S82- S86, 1991
Naoumov NV, Schneider R, Groetzinger T, Jung MC, Miska S, Pape GR, Will H: Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 102:538 - 543, 1992
Lai ME, Solinas A, Mazzoleni A, Deplano A, Farci P, Lisci V, Porru A, e t al: The role of precore hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study. J Hepatol 20:773- 781, 1994
Ljunggren KK, Nordenfelt E, Kidd A: Correlation of HBeAg/ anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive patients. J Med Virol 39:297- 302, 1993
Peters M, Vierling J, Gershwin ME, Milich D, Chisari FV, Hoofnagle J: Immunology and the liver. Hepatology 13:977- 994, 1991
Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29 - 60, 1995
Bertoletti A, Chisari FV, Penna A, Guilhot S, Galati L, Missale G, Fowler P, Schlicht HJ, Vitiello A, Chesnut RC: Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol 67:2376 - 2380, 1993
Milich DR, McLachlan A, Moriarty A, Thornton GB: Immune response to hepatitis B virus core antigen (HBcAg): Localization of T cell recognition sites within HBcAg/HBe Ag. J Immunol 139:1223- 1231, 1987
Ferrari C, Penna A, Giuberci T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV: Intrahepatic nucleocapsid antigen specific T cell in chronic active hepatitis B. J Immunol 139:2050 - 2058, 1987
Ehata T, Omata T, Yokosuka O, Hosoda K, Ohto M: Variations in codon 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest 89:332- 338, 1992
Chuang W-L, Omata M, Ehata T, Yokosuka O, Ito Y, Imazeki F, Lu S-N, Chang W-Y, Ohto M: Pre core mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology 104:263- 271, 1993
Tsai S-L, Chen M-H, Yeh C-T, Chu C-M, Lin A-N, Chiou F-H, Chang T-H, Liaw Y-F: Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD81 cytotoxicTlymphocytes. J Clin Invest 97:577- 584, 1996
Lee P-I, Chang M-H, Lee C-Y, Hsu H-Y, Chen J-S, Chen P-J, Chen D-S: Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis infection in children. Hepatology 12:657- 660, 1990
Bortolotti F, Cadrobbi P, Crivellaro C, Guido M, Rugge M, Noventa F, Calzia R, Realdi G: Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 99:805- 810, 1990
De Franchis R, Mucci G, Vecchi M, Tatarella M, Colombo M, Ninno ED, Rumi MG, Donato MF, Ronchi G: Natural history of asymptomatic hepatitis B surface antigen carriers. Annals Int Med 118:191- 194, 1993
Villeneuve J-P, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourciere M, Cote J, Riche r G: A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 106:1000 - 1005, 1994
Raimondo G, Meucci G, Sardo MA, Rodino G, Campo S, Vecchi M, Pernice M, Rumi MG, Tatarella M, De Franchis R: Persistence of “ wild type ” and “ e-minus” hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers. J Hepatol 20:148 - 151, 1994
Davis GL, Hoofnagle J: Reactivation of chronic type B hepatitis presenting as acute viral hepatitis. Ann Intern Med 102:762- 765, 1985
Lok ASF, Liang RHS, Chiu EKW, Wong K-L, Chan T-K, Todd D: Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 100:182- 188, 1991
Yoshiba M, Sekiyama K, Sugata F, Okamoto H, Yamamoto K, Yotsumoto S: Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 37:1253- 1259, 1992
Carman WF, McIntyre G, Hadziyannis S, Fattovich G, Alberti A, Thomas HC: Core protein evolution after selection of hepatitis B precore mutants and correlation with disease se-verity. InViral Hepatitis and Liver Disease. K Nishioka, H Suzuki, S Mishiro, T Oda (eds). Tokyo, Springer-Verlag, 1994, pp 273- 276
Kobayashi M, Koike K: Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene 30:227- 232, 1984
Knode ll RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431- 435, 1981
Trevisian A, Gudet F, Busachi C, Stocklin E, Bianchi L: An improved method for HBcAg demonstration in paraffinembedde d liver tissue. Liver 2:331- 339, 1982
Maruyama T, Iino S, Koike K, Yasuda K, Milich DR: Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 105:1141- 1151, 1993
Scaglioni PP, Melegari M, Wands JR: Characterization of hepatitis B virus core mutants that inhibit viral replication. Virology 205:112- 120, 1994
Hatton T, Zhou S, Standring DN: RNA-and DNA-binding activities in hepatitis B virus capsid protein: A model for their roles in viral replication. J Virol 66:5232- 5241, 1992
Tong S-P, Li J-S, Vitviski L, Trepo C: Replication capabilities of natural and artificial precore stop codon mutants of hepatitis B virus; relevance of pregenome encapsidation signal. Virology 191:237- 245, 1992
Rights and permissions
About this article
Cite this article
Fujiwara, K., Yokosuka, O., Ehata, T. et al. The Two Different States of Hepatitis B Virus DNA in Asymptomatic Carriers (HBe-Antigen-Positive versus Anti-HBe-Positive Asymptomatic Carriers). Dig Dis Sci 43, 368–376 (1998). https://doi.org/10.1023/A:1018870709286
Issue Date:
DOI: https://doi.org/10.1023/A:1018870709286